- Home
- ABCB vs LEGN Comparison
ABCB vs LEGN Comparison
Compare ABCB & LEGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABCB | LEGN |
|---|---|---|
| Founded | 1971 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.9B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | ABCB | LEGN |
|---|---|---|
| Price | $78.93 | $23.08 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 13 |
| Target Price | ★ $79.57 | $69.33 |
| AVG Volume (30 Days) | 468.5K | ★ 2.2M |
| Earning Date | 01-29-2026 | 11-12-2025 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 20.70 | N/A |
| EPS | ★ 5.77 | N/A |
| Revenue | ★ $1,130,299,000.00 | $909,045,000.00 |
| Revenue This Year | $13.82 | $68.52 |
| Revenue Next Year | $4.87 | $48.63 |
| P/E Ratio | $13.32 | ★ N/A |
| Revenue Growth | 7.96 | ★ 74.75 |
| 52 Week Low | $48.27 | $20.21 |
| 52 Week High | $78.99 | $45.30 |
Technical Indicators
Market Signals| Indicator | ABCB | LEGN |
|---|---|---|
| Relative Strength Index (RSI) | 64.03 | 46.83 |
| Support Level | $73.32 | $20.21 |
| Resistance Level | $76.82 | $22.07 |
| Average True Range (ATR) | 1.47 | 0.85 |
| MACD | 0.03 | 0.34 |
| Stochastic Oscillator | 91.03 | 93.07 |
Price Performance
Historical ComparisonAbout ABCB Ameris Bancorp
Ameris Bancorp is a bank holding company that operates through Ameris Bank, its subsidiary. The company operates branches in Georgia, Alabama, Florida, and South Carolina. It offers traditional banking services such as business banking, personal banking, checking, savings, mobile banking, and others. The bank is organized into four segments: the Banking Division, the Retail Mortgage Division, the Warehouse Lending Division and the Premium Finance Division. The company generates majority of its revenue from the banking division. Ameris intends to acquire banks in its geographic region to increase its market share and expand beyond its current market.
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.